This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time.
The study will include adults without diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS.
Researchers will study whether participants develop diabetes after surgery and whether this risk changes according to the type of pancreatic resection.
Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.
Adult patients (≥18 years)
No diabetes mellitus at baseline
Undergoing partial, near-total, or total pancreatectomy at the study center
Availability of clinical and metabolic data according to study component
Diabetes mellitus at baseline
Age <18 years
Missing key clinical data precluding eligibility assessment or primary outcome evaluation
Refusal or inability to provide informed consent for the prospective component, where applicable
Adult patients without diabetes at baseline undergoing partial, near-total, or total pancreatectomy according to routine clinical practice for benign or malignant pancreatic diseases at Fondazione Policlinico Universitario Agostino Gemelli IRCCS, including retrospective, ambispective, and prospective study components.
Cohort
Other
Not listed
Incidence of New-Onset Diabetes Mellitus After Pancreatectomy
Incidence of new-onset diabetes mellitus in participants without diabetes at baseline according to the type of pancreatic resection.
To assess the deterioration of glucose metabolism during post-pancreatectomy follow-up
To assess the deterioration of glucose metabolism during post-pancreatectomy follow-up, defined as worsening of glycemic control parameters and/or the initiation or intensification of glucose-lowering therapy in patients without diabetes mellitus at baseline
Click on the lead sponsor to view all of their trials.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead sponsor
European Foundation for the Study of Diabetes
Collaborator
